Oncoclínicas do Brasil Serviços Médicos S.A.

B3:ONCO3.SA

5.59 (BRL) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 3.3029.59275.439149.33234.9741.22296.94457.047-24.596-15.62522.729150.789-202.5286.593-123.51614.069-9.327-20.392
Depreciation & Amortization 69.73367.64965.87468.53262.70960.2543.39449.59447.18434.9835.90427.18436.01427.87133.87624.61122.06623.212
Deferred Income Tax -26.905-79.544-10.097-166.804-22.047-12.826-65.928-63.444-0.1864.3496.138-2.5091.179-4.4310000
Stock Based Compensation 10.3235.77411.71113.94813.2647.92-12.02505.2885.2862.074-136.764195.4358.418121.176-6.2843.3323.332
Change In Working Capital -249.41-309.168-278.74151.08881.74-362.63747.522-1.61-350.827-208.472-32.2574.809-157.652-32.193-51.126-40.037-5.328-29.592
Accounts Receivables -307.802-421.132-255.367-49.57623.92-329.091-354.019-103.562-239.704-107.802-45.636-99.346-44.37-54.519-2.263-32.218-40.666-40.666
Change In Inventory -16.824-47.848-74.706-1.8821.82912.493-32.088-2.7587.171-42.617-9.079-2.248-9.371-3.52-1.671-11.166-1.17-6.026
Change In Accounts Payables 71.40758.648-35.40198.26170.246-73.939322.77979.921-108.279-31.86831.63953.413-61.99924.6990000
Other Working Capital 3.809101.16486.7334.284-134.25527.9110.8524.789-10.015-165.855-23.1787.057-148.281-28.673-49.4553.34736.509-23.566
Other Non Cash Items 448.588724.045-70.355-45.406-3.43314.419-56.128-87.62479.4517.123-0.656-111.829214.6211.318115.07460.3724.51912.083
Operating Cash Flow -147.377-133.056-206.169223.546175.986-246.746131.73217.407-248.789-171.99425.7270.953-109.5453.589-25.69252.72935.261-14.689
Investing Activities:
Investments In Property Plant And Equipment -105.321-50.80196.047-116.885-90.997-44.267-65.514-130.25-59.811-48.604-123.867-36.471-21.059-20.548-87.001-8.52-54.641-92.62
Acquisitions Net 0-142-0.3030.013-5.114-8.25-10.379-521.393-48.95-251.661-281.868-174.13200-61.398-22.318-1.493-1.493
Purchases Of Investments -1,444.7240-155.593-138.1100332.645-77.9411.1390-1,431.40000000
Sales Maturities Of Investments -207.136207.136-179.288138.11118.353478.919-332.64577.941388.632600.464-46.075-0.469-0.78347.3270000
Other Investing Activites -235.392-100.746-40.067175.9662.229-2.932-340.06475.931-1.823.558-1,414.612-174.345-2.827-0.85825.481-43.797-22.708-0.299
Investing Cash Flow -1,963.87855.589-279.20459.09424.471423.47-415.957-575.712279.19303.757-1,820.347-210.816-24.66925.921-122.918-74.635-78.841-92.919
Financing Activities:
Debt Repayment -836.763-155.968-942.059-133.463-277.877-47.366-305.841-192.582-88.511-161-271.784-57.048-35.19-154.8-453.908-276.6660-17.246
Common Stock Issued 1,5000-15.8748.583201.8743.126-3.249512.09612.8621.77210.3931,779.1640.7620.1428.36000.961
Common Stock Repurchased 127.725-145.5859.41516.931-22.458-28.211-5.354-58.408-1.255-13-72.506-50.608-51.621149.955727.834-0.049-25.935-25.935
Dividends Paid -2.3540-22.535-27.27-9.249-0.659-11.231-1.696-2.795-2.569-20.603-0.579-3.416-1.8-31.99-13.089-0.069-0.069
Other Financing Activities -151.493-58.11,454.706-187.3448.04843.089760.211-88.9650.06456.534912.06-116.495-162.58179.607696.751-9.72665.055-3.663
Financing Cash Flow 2,297.755-60.467483.657-282.559-59.662-30.021434.536170.445-79.635-118.263557.561,554.434-200.425-76.851219.213253.80239.052-19.948
Other Information:
Effect Of Forex Changes On Cash 0.312-0.0030.0840.011-0.128-0.154-0.0880.22-0.056-0.4230.3220.101003.402-3.40200
Net Change In Cash 137.82-137.9370.1880.092140.667146.549150.223-387.64-49.2913.077-1,236.6831,414.713-334.639-47.34174.005228.494-4.529-127.556
Cash At End Of Period 550.587412.767550.704550.516550.424409.757263.208112.985500.625549.915536.8381,773.521358.808693.447740.788666.783-4.529319.79